Tag: equity
-
Synthetic Bio Milk Company Gains $13M in Seed Funds
A start-up enterprise creating milk and dairy products with proteins derived from engineered microorganisms is raising $13 million in seed funds.
-
New Company to Develop Synthetic Antibody Therapies
A new business is underway to develop and commercialize treatments for Covid-19 and other diseases based on synthetic antibody proteins.
-
Cell Therapy Biotech Raises $75.5M in Venture Funds
A developer of off-the-shelf genetically engineered platelet cells to treat a range of diseases is raising $75.5 million in its second venture round.
-
Synthetic Protein Company Gains $25M in New Funds
A company designing engineered proteins to work better than natural chemistries as treatments for disease is raising $25 million in its first venture round.
-
Infographic – Record Q3 Global Health Investments
Venture investment volumes in health care and life science start-up companies hit record levels so far in 2021, already surpassing levels for all of 2020.
-
Infographic – Q3 2021 Venture Funds Continue Banner Year
Venture investors worldwide continue to look past the pandemic as investments in start-up enterprises rose to new levels in the U.S., Asia, and elsewhere.
-
AI-Designed Antibodies for Start-Up Sought in Open Call
An international consortium is seeking teams of scientists using algorithms to design new therapeutic antibodies, to form and fund a start-up company.
-
European Life Science Venture Fund Raises €472M
A venture capital company raised €472 million ($US 548 million) for investments in life science and medical device start-ups in Europe.
-
Crispr Licensed for Eye Disease Gene Therapies
A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes.
-
Infographic – Cruising Biotech Index Takes Late Dip
NBI, an indicator of investor sentiment in the industry, continued its choppy climb through most of the third quarter, only to start another decline in late September.